MARTIN KRAKOWER: Open Payments
NPI 1073615738 · PHOENICIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127 in 6 payments from 5 companies in 2025. Trend: 2023 $1,022 · 2024 $171 · 2025 $127
Food & beverage: $127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $54 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: QULIPTA, TRELEGY ELLIPTA, JARDIANCE, Ozempic, FARXIGA.
Industry payments across NY — which companies pay providers there.
